FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896444913> ?p ?o ?g. }

• W2896444913 abstract "Background: Stroke prophylaxis in patients with atrial fibrillation (AF) and heart failure (HF) in the era of direct oral anticoagulants is not well characterized. Using data from American Heart Association Get With The Guidelines–AFIB, we sought to evaluate oral anticoagulation (OAC) use at discharge among AF patients with concomitant HF. Methods and Results: AF patients with a diagnosis of HF hospitalized from January 2013 to March 2017 were included. We compared patient characteristics and use of OAC at discharge among patients with reduced (redundant ejection fraction [EF], EF≤40%), borderline (40%<EF<50%), and preserved (EF≥50%) EF using multivariable mixed logistic regression models. Among 10 883 patients with AF and HF, 1790 (16.4%) had a reported contraindication to anticoagulation and were excluded from further analysis. Among 9093 patients eligible for OAC, 3499 (38.5%) had HF with reduced EF, 1062 (11.7%) had HF with borderline EF, and 4532 (49.8%) had HF with preserved EF. The median CHA 2 DS 2 -VASc score was 5 (Q1, Q3; 3, 6) among all patients and higher among those with HF with preserved EF than HF with reduced EF (5 [4, 6] versus 4 [3, 5]; P <0.0001). The proportion of eligible patients discharged on OAC was 94.9%, with 43.6% discharged on warfarin and 50.7% discharged on direct oral anticoagulants. A higher proportion of patients with HF with reduced EF and HF with borderline EF were discharged on direct oral anticoagulants than with HF with preserved EF, but the difference was small (52.8%, 53.1% versus 48.5%, respectively; P =0.0002). EF group was not significantly associated with a patient’s OAC use at discharge. Conclusions: In the context of American Heart Association Get With The Guidelines–AFIB, a quality improvement program, the rate of use of OAC at discharge in eligible AF patients with HF was almost 95%. To our knowledge, these rates represent some of the highest use of appropriate anticoagulation for patients in a national registry to date." @default.
• W2896444913 created "2018-10-26" @default.
• W2896444913 creator A5001739506 @default.
• W2896444913 creator A5014449865 @default.
• W2896444913 creator A5023346746 @default.
• W2896444913 creator A5026475907 @default.
• W2896444913 creator A5026578587 @default.
• W2896444913 creator A5029926431 @default.
• W2896444913 creator A5054215335 @default.
• W2896444913 creator A5056714267 @default.
• W2896444913 creator A5067237537 @default.
• W2896444913 creator A5068642565 @default.
• W2896444913 creator A5070928171 @default.
• W2896444913 creator A5084326780 @default.
• W2896444913 creator A5085175606 @default.
• W2896444913 date "2018-10-01" @default.
• W2896444913 modified "2023-10-14" @default.
• W2896444913 title "Use of Oral Anticoagulation in Eligible Patients Discharged With Heart Failure and Atrial Fibrillation" @default.
• W2896444913 cites W104425974 @default.
• W2896444913 cites W191827969 @default.
• W2896444913 cites W1966087026 @default.
• W2896444913 cites W1999468381 @default.
• W2896444913 cites W2000750844 @default.
• W2896444913 cites W2011188945 @default.
• W2896444913 cites W2011936209 @default.
• W2896444913 cites W2023603860 @default.
• W2896444913 cites W2073572483 @default.
• W2896444913 cites W2092107875 @default.
• W2896444913 cites W2092929484 @default.
• W2896444913 cites W2096246254 @default.
• W2896444913 cites W2097854437 @default.
• W2896444913 cites W2107019564 @default.
• W2896444913 cites W2107604758 @default.
• W2896444913 cites W2109712401 @default.
• W2896444913 cites W2121394112 @default.
• W2896444913 cites W2127985968 @default.
• W2896444913 cites W2129962350 @default.
• W2896444913 cites W2133435868 @default.
• W2896444913 cites W2136489990 @default.
• W2896444913 cites W2144471064 @default.
• W2896444913 cites W2152623033 @default.
• W2896444913 cites W2156613835 @default.
• W2896444913 cites W2159370853 @default.
• W2896444913 cites W2162508946 @default.
• W2896444913 cites W2162586165 @default.
• W2896444913 cites W2170350621 @default.
• W2896444913 cites W2171360908 @default.
• W2896444913 cites W2178738676 @default.
• W2896444913 cites W2258863059 @default.
• W2896444913 cites W2298220628 @default.
• W2896444913 cites W2549994024 @default.
• W2896444913 cites W2593458580 @default.
• W2896444913 cites W2595567103 @default.
• W2896444913 cites W2616300024 @default.
• W2896444913 cites W2791453970 @default.
• W2896444913 cites W2884532285 @default.
• W2896444913 cites W2886027203 @default.
• W2896444913 cites W2887390048 @default.
• W2896444913 cites W2897495391 @default.
• W2896444913 doi "https://doi.org/10.1161/circheartfailure.118.005356" @default.
• W2896444913 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6319668" @default.
• W2896444913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30354398" @default.
• W2896444913 hasPublicationYear "2018" @default.
• W2896444913 type Work @default.
• W2896444913 sameAs 2896444913 @default.
• W2896444913 citedByCount "5" @default.
• W2896444913 countsByYear W28964449132020 @default.
• W2896444913 countsByYear W28964449132021 @default.
• W2896444913 countsByYear W28964449132022 @default.
• W2896444913 countsByYear W28964449132023 @default.
• W2896444913 crossrefType "journal-article" @default.
• W2896444913 hasAuthorship W2896444913A5001739506 @default.
• W2896444913 hasAuthorship W2896444913A5014449865 @default.
• W2896444913 hasAuthorship W2896444913A5023346746 @default.
• W2896444913 hasAuthorship W2896444913A5026475907 @default.
• W2896444913 hasAuthorship W2896444913A5026578587 @default.
• W2896444913 hasAuthorship W2896444913A5029926431 @default.
• W2896444913 hasAuthorship W2896444913A5054215335 @default.
• W2896444913 hasAuthorship W2896444913A5056714267 @default.
• W2896444913 hasAuthorship W2896444913A5067237537 @default.
• W2896444913 hasAuthorship W2896444913A5068642565 @default.
• W2896444913 hasAuthorship W2896444913A5070928171 @default.
• W2896444913 hasAuthorship W2896444913A5084326780 @default.
• W2896444913 hasAuthorship W2896444913A5085175606 @default.
• W2896444913 hasBestOaLocation W28964449131 @default.
• W2896444913 hasConcept C126322002 @default.
• W2896444913 hasConcept C127413603 @default.
• W2896444913 hasConcept C142724271 @default.
• W2896444913 hasConcept C151956035 @default.
• W2896444913 hasConcept C164705383 @default.
• W2896444913 hasConcept C204787440 @default.
• W2896444913 hasConcept C2776301958 @default.
• W2896444913 hasConcept C2776494729 @default.
• W2896444913 hasConcept C2778198053 @default.
• W2896444913 hasConcept C2779161974 @default.
• W2896444913 hasConcept C2779384505 @default.
• W2896444913 hasConcept C2780645631 @default.
• W2896444913 hasConcept C71924100 @default.
• W2896444913 hasConcept C78085059 @default.
• W2896444913 hasConcept C78519656 @default.

• next